Pharmabiz

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...

Radiopharmaceuticals Market Research Report 2026: $11.66 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecast - Valuates Reports

Global Radiopharmaceuticals Market Size The global Radiopharmaceuticals market revenue was USD 6761 Million in 2022 and is ...
Le Lézard

Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus

Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...
Times Union

Commentary: Support nuclear power by extending the Zero-Emission Credit program

New York is one of a kind. Our ambitions have always inspired others, and our economic decisions send ripples throughout the country and the world. In 2019, we embraced that spirit by committing to ...
The Cincinnati Enquirer

Jamieson M. Bourque, MD, MHS, FASNC, Installed as 2026 President of the American Society of Nuclear Cardiology

During my tenure as ASNC president, I will work tirelessly so we can innovate together as the global community of nuclear cardiology professionals.” — Jamieson M. Bourque, MD, MHS, FASNC, ASNC ...